Several studies have identified increased circulating levels of progranulin in obesity and type II diabetes26–28, however, no changes were observed in the circulating analytes β-hydroxybutyric acid (BHBA), cholesterol, non-fasted glucose, or circulating triglyceride levels (Supplemental Fig. S2). Here, GRN is linked to obesity disorder.